|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss from discontinued operations | |||||
| Net income from continuing operations | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities: | |||||
| Changes in allowances - accounts receivable | |||||
| Changes in allowances - advances to suppliers | |||||
| Depreciation and amortization | |||||
| Changes in allowances - inventories | |||||
| Changes in allowances - other current assets | |||||
| Changes in allowances - due from related parties | |||||
| Changes in allowances - long-term investment | |||||
| Changes in impairment - biological assets | |||||
| Depreciation | |||||
| Amortization of operating lease right-of-use assets | |||||
| Non-cash lease expenses | |||||
| Loss on short-term investment | |||||
| Loss on disposal of property and equipment | |||||
| Accrued interest expense for convertible notes | |||||
| (Gain) (loss) from disposal of subsidiaries | |||||
| Amortization of debt issuance costs | |||||
| Interest receivable from other receivable | |||||
| Interest expenses for promissory note redemption | |||||
| Amortization of biological assets | |||||
| Deferred income tax provision | |||||
| Change in fair value of derivative liability | |||||
| Share-based compensation | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Advances to suppliers, net | |||||
| Note receivable | |||||
| Inventories, net | |||||
| Other current assets | |||||
| Other non-current assets - security deposits | |||||
| Accounts payable | |||||
| Operating lease liabilities | |||||
| Other current liabilities | |||||
| Net cash provided by (used in) operating activities from continuing operations | |||||
| Net cash provided by operating activities from discontinued operations | |||||
| Other non-current liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of property and equipment | |||||
| Purchase of intangible assets | |||||
| Additions to biological assets | |||||
| Advances to a third party | |||||
| Short-term deposits | |||||
| Acquisition of subsidiaries | |||||
| Repayment of advances to a third party | |||||
| Proceeds from disposal of subsidiaries, net of cash | |||||
| Cash paid for investment | |||||
| Purchase of short-term investments | |||||
| Other receivables | |||||
| Advances to related parties | |||||
| Repayment of advances to related party | |||||
| Net cash used in investing activities from continuing operations | |||||
| Net cash used in investing activities from discontinued operations | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from promissory notes | |||||
| Repayment of promissory notes | |||||
| Repayment of convertible promissory notes | |||||
| Borrowings from a third party loan | |||||
| Repayment of a third party loan | |||||
| Gross proceeds from bank acceptance notes payable | |||||
| Repayment of bank acceptance notes payable | |||||
| Proceed from issuance of ordinary shares for warrants exercised | |||||
| Net proceeds from convertible promissory note issuance | |||||
| Proceed from issuance of ordinary shares, net | |||||
| Borrowing from bank loans | |||||
| Repayments of bank loans | |||||
| Repayment of advances from related parties | |||||
| Proceeds from advances from related parties | |||||
| Net cash provided by financing activities from continuing operations | |||||
| Net cash (used by) provided by financing activities from discontinued operations | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net increase (decrease) in cash | |||||
| Cash and restricted cash, beginning of year | |||||
| Cash and restricted cash, end of year | |||||
| Cash | |||||
| Restricted cash | |||||
| Cash from continuing operations | |||||
| Cash from discontinued operations | |||||
| Representing: | |||||
| Cash, end of year | |||||
| Less: cash from discontinued operations | |||||
| Restricted cash, end of year | |||||
| Total cash and restricted cash, end of year | |||||
| Income taxes paid | |||||
| Interest paid | |||||
| Non-cash investing activities | |||||
| Note receivable for refund due from cancelled investment | |||||
| Non-cash financing activities | |||||
| Right-of-use assets obtained in exchange for operating lease obligations | |||||
| Issuance of ordinary shares for promissory notes redemption | |||||
| Interest expenses for promissory note redemption | |||||
Loading...